Optimisation and individualisation of HeartSparing breast radiotherapy techniques (The HeartSpare Study): Stage II
Not Applicable
Completed
- Conditions
- Breast cancerCancerMalignant neoplasm of breast
- Registration Number
- ISRCTN62239447
- Lead Sponsor
- Royal Marsden NHS Foundation Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
1. Women or men with left-sided breast cancer
2. Recommendation for whole breast or chest wall RT within FAST-Forward trial
3. Patients with any heart tissue in a tangential RT field placed according to standard anatomical borders
3. Any breast volume
4. Eastern Cooperative Oncology Group (ECOG) performance status <=1
5. Patients able to tolerate breath-hold
Exclusion Criteria
1. Right-sided breast cancer
2. Ineligible for whole breast or chest wall RT within FAST-Forward trial
3. Patients with micro- or macro-scopic disease on sentinel node biopsy who have not undergone completion axillary node clearance
4. Previous radiotherapy to any region above the diaphragm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method